Stock DNA
Pharmaceuticals & Biotechnology
INR 820 Cr (Micro Cap)
181.00
40
0.00%
0.36
16.26%
28.84
Total Returns (Price + Dividend) 
Aptus Pharma for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations 2015
12-Nov-2026 | Source : BSEOutcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations 2015
Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis
06-Nov-2026 | Source : BSEAptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis
Receipt Of In-Principle Approval For Preferential Issue
30-Oct-2026 | Source : BSEReceipt of In-Principle Approval for Preferential Issue
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Tejash Maheshchandra Hathi (11.44%)
None
24.55%